WO1996022305A3 - Modified peptides - Google Patents
Modified peptides Download PDFInfo
- Publication number
- WO1996022305A3 WO1996022305A3 PCT/GB1996/000057 GB9600057W WO9622305A3 WO 1996022305 A3 WO1996022305 A3 WO 1996022305A3 GB 9600057 W GB9600057 W GB 9600057W WO 9622305 A3 WO9622305 A3 WO 9622305A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- modified peptides
- compounds
- prophylaxis
- formula
- treatment
- Prior art date
Links
- 108091005601 modified peptides Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000030814 Eating disease Diseases 0.000 abstract 1
- 208000019454 Feeding and Eating disease Diseases 0.000 abstract 1
- 235000014632 disordered eating Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
- C07K5/06095—Arg-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to compounds of formula (I), to the use of such compounds in medicine especially in the treatment or prophylaxis of conditions associated with eating disorders and to pharmaceutical compositions containing such compounds.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU43943/96A AU4394396A (en) | 1995-01-12 | 1996-01-12 | Modified peptides |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9500601.1A GB9500601D0 (en) | 1995-01-12 | 1995-01-12 | Modified peptides |
GB9500601.1 | 1995-01-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1996022305A2 WO1996022305A2 (en) | 1996-07-25 |
WO1996022305A3 true WO1996022305A3 (en) | 1996-09-06 |
Family
ID=10767945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1996/000057 WO1996022305A2 (en) | 1995-01-12 | 1996-01-12 | Modified peptides |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU4394396A (en) |
GB (1) | GB9500601D0 (en) |
WO (1) | WO1996022305A2 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2814367B1 (en) * | 2000-09-25 | 2008-12-26 | Inst Nat Sante Rech Med | NPFF RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN AND HYPERALGIA |
SE0103476D0 (en) * | 2001-10-18 | 2001-10-18 | Markus Heilig | New use |
ZA200508439B (en) | 2003-05-05 | 2007-03-28 | Probiodrug Ag | Medical use of inhibitors of glutaminyl and glutamate cyclases |
US20050137142A1 (en) | 2003-11-03 | 2005-06-23 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
US7304086B2 (en) | 2004-02-05 | 2007-12-04 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
US8278345B2 (en) | 2006-11-09 | 2012-10-02 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
US9126987B2 (en) | 2006-11-30 | 2015-09-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
CN101668525A (en) | 2007-03-01 | 2010-03-10 | 前体生物药物股份公司 | New use of glutaminyl cyclase inhibitors |
EP2142514B1 (en) | 2007-04-18 | 2014-12-24 | Probiodrug AG | Thiourea derivatives as glutaminyl cyclase inhibitors |
BR112012008346B1 (en) | 2009-09-11 | 2021-12-21 | Vivoryon Therapeutics N.V. | HETEROCYCLIC DERIVATIVES, THEIR PREPARATION PROCESS, AND PHARMACEUTICAL COMPOSITION |
EP2542549B1 (en) | 2010-03-03 | 2016-05-11 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
KR101790806B1 (en) | 2010-03-10 | 2017-11-20 | 프로비오드룩 아게 | Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
EP2560953B1 (en) | 2010-04-21 | 2016-01-06 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
ES2570167T3 (en) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Benzimidazole derivatives as glutaminyl cyclase inhibitors |
EP3461819B1 (en) | 2017-09-29 | 2020-05-27 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994017035A1 (en) * | 1993-01-20 | 1994-08-04 | Dr. Karl Thomae Gmbh | Aminoacid derivates, medicaments containing these compounds and process for preparing the same |
-
1995
- 1995-01-12 GB GBGB9500601.1A patent/GB9500601D0/en active Pending
-
1996
- 1996-01-12 AU AU43943/96A patent/AU4394396A/en not_active Abandoned
- 1996-01-12 WO PCT/GB1996/000057 patent/WO1996022305A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994017035A1 (en) * | 1993-01-20 | 1994-08-04 | Dr. Karl Thomae Gmbh | Aminoacid derivates, medicaments containing these compounds and process for preparing the same |
Also Published As
Publication number | Publication date |
---|---|
WO1996022305A2 (en) | 1996-07-25 |
AU4394396A (en) | 1996-08-07 |
GB9500601D0 (en) | 1995-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000047568A3 (en) | 1,2-benzothiazepines for the treatment of hyperlipidemic diseases | |
BG101118A (en) | Therapeutical compounds | |
CA2163361A1 (en) | Therapeutic substituted guanidines | |
UA39158C2 (en) | derivatives of N4-oxycarbonyl- 5'-deoxy-5-fluorocytidine and pharmaceutical preparation based thereon | |
CA2100212A1 (en) | Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura | |
MY128654A (en) | Liquid pharmaceutical composition containing an erythropoietin derivative | |
WO1996022305A3 (en) | Modified peptides | |
NZ247201A (en) | Substituted sulphonylamido- or sulphonamidocarbonyl-pyridine-2-carboxamide derivatives and pharmaceutical compositions | |
MX9709238A (en) | Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders. | |
GR3022510T3 (en) | Lyospheres comprising gonadotropin | |
ZA965294B (en) | Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them. | |
CA2338600A1 (en) | Novel thiazolopyrimidine compounds | |
CA2129995A1 (en) | Piperidinyl thiacyclic derivatives | |
WO1996021468A3 (en) | Chemically modified interferon | |
MY120976A (en) | 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines | |
CA2343732A1 (en) | Substituted .gamma.-phenyl-.delta.-lactones and analogs thereof and uses related thereto | |
BG102250A (en) | The use of marigold-extracted glycosides for the treatment of psoriasis | |
TW268937B (en) | ||
ZA947957B (en) | Substituted 1-naphthyl-3-pyrazolecarboxamides which are active in neurotensin their preparation and pharmaceutical compositions containing them | |
MXPA94009086A (en) | Therapeutic substituted guanidines. | |
IL126235A (en) | Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use | |
AU6415994A (en) | Substituted caprolactams and derivatives thereof useful for treatment of hiv disease | |
CA2047802A1 (en) | Pharmaceutical compositions | |
IL102032A0 (en) | 2-amino-5-cyano-1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them | |
AU7941294A (en) | Composition for the treatment or prevention of herpes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AZ BY KZ RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |